Cyclobenzaprine Hydrochloride
NDC 85509-1035, Cyclobenzaprine Hydrochloride, capsule, extended release, from PHOENIX RX LLC.
- Product NDC
- 85509-1035
- Status
- Listed
- Labeler
- PHOENIX RX LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091281
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85509-1035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE15 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85509-1035-3 | 85509103503 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85509-1035-3) |
| 85509-1035-6 | 85509103506 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85509-1035-6) |
| 85509-1035-9 | 85509103509 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85509-1035-9) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/48c33e51-db07-af68-e063-6294a90a897e
Use it
Look up 85509-1035 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85509-1035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85509-1035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.